Crystalline forms of n,n-dimethyltryptamine and methods of using the same
AssigneeAtai Therapeutics, Inc.
InventorsMajed Fawaz, Setu Kasera
Life of this patent
Estimating the term…
Abstract
The present disclosure provides crystalline forms of N,N-dimethyltryptamine, Also provided herein are methods of using crystalline forms of N,N-DMT and compositions comprising the same, e.g., in the treatment of mental health diseases and/or disorders.
Claims42
Form IV of N,N-dimethyltryptamine.
canceled
canceled
canceled
canceled
canceled
canceled
canceled
canceled
canceled
canceled
canceled
Form III of N,N-dimethyltryptamine.
canceled
canceled
canceled
canceled
canceled
A pharmaceutical composition comprising Form Ill or Form IV of N,N-dimethyltryptamine and a pharmaceutically acceptable excipient.
canceled
canceled
canceled
A method of treating post-traumatic stress disorder (PTSD), depression, or an anxiety disorder in a subject in need thereof, comprising administering a therapeutically effective amount of a Form IV of N,N-dimethyltryptamine, a Form III of N,N-dimethyltryptamine, or a pharmaceutical composition of a Form Ill or a Form IV of N,N-dimethyltryptamine to the subject.
canceled
canceled
canceled
Dependencies are inferred from the claim text.